Supernus, Inc. (SUPN) shareholders
Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –
Ownership
Who owns Supernus's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 17,806,183 | 14.30% | 13G (passive) amendment | Dec 31, 2025 |
| Deerfield Management Company, L.P. Joint filing with Deerfield Mgmt, L.P. (8.47%), Deerfield Partners, L.P. (8.47%) and 1 more | 10,567,160 | 8.47% | 13G (passive) amendment | Mar 31, 2025 |
| The Goldman Sachs Group, Inc. Joint filing with Goldman Sachs & Co. LLC (7.80%) | 9,789,169 | 7.80% | 13G (passive) amendment | Jun 30, 2025 |
| Sina Toussi Joint filing with Two Seas Capital LP (7.40%), Two Seas Capital GP LLC (7.40%) | 9,254,152 | 7.40% | 13D (active) amendment | Nov 3, 2025 |
| Deerfield Mgmt, L.P. Joint filing with Deerfield Management Company, L.P. (7.16%), Deerfield Partners, L.P. (7.16%) and 1 more | 8,883,160 | 7.16% | 13G (passive) amendment | Dec 31, 2024 |
| Oaktree Capital Group Holdings GP, LLC Joint filing with Oaktree Capital Holdings, LLC (7.00%), Oaktree Fund GP I, L.P. (5.90%) | 8,745,084 | 7.00% | 13D (active) amendment | Nov 10, 2025 |
| Vanguard Portfolio Management | 7,994,836 | 6.55% | 13G (passive) | Mar 31, 2026 |
| Madison Avenue GP, LLC Joint filing with Madison Avenue International LP (6.00%), Madison Avenue Partners, LP (6.00%) and 3 more | 7,438,153 | 6.00% | 13G (passive) | Mar 11, 2025 |
| Two Seas Capital LP Joint filing with Two Seas Capital GP LLC (5.70%), Sina Toussi (5.70%) | 7,061,854 | 5.70% | 13D (active) amendment | Dec 8, 2025 |
| Vanguard Capital Management | 6,523,720 | 5.35% | 13G (passive) | Mar 31, 2026 |
| Israel A. Englander Joint filing with Millennium Management LLC (5.40%), Millennium Group Management LLC (5.40%) | 6,343,651 | 5.40% | 13G (passive) | Sep 23, 2026 |
| Madison Avenue International LP Joint filing with Madison Avenue Partners, LP (5.00%), EMAI Management, LLC (5.00%) and 3 more | 6,280,502 | 5.00% | 13G (passive) amendment | Dec 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jack A. Khattar | Chief Executive Officer, Director | 3,413,555 | 2.89% | Nov 4, 2026 |
| Joseph Ciaffoni | Chief Executive Officer, Director | 790,330 | 0.67% | Jun 23, 2026 |
| Frank Mottola | SVP, Chief Tech. Ops. Officer | 30,099 | 0.03% | Nov 4, 2026 |
| Timothy C. Dec | SVP, Chief Financial Officer | 14,059 | 0.01% | Nov 4, 2026 |
| Jonathan Rubin | SVP, Chief Medical Officer | 21,529 | 0.02% | Nov 4, 2026 |
| Padmanabh P. Bhatt | SVP of IP, CSO | 28,702 | 0.02% | Nov 4, 2026 |
| William Todd Horich | SVP, Chief Commercial Officer | – | – | Nov 4, 2026 |
| Woodrow D. Anderson | Chief Accounting Officer | 27,638 | 0.02% | Aug 27, 2026 |
| Christian Heidbreder | Chief Scientific Officer | 209,337 | 0.18% | Jul 13, 2026 |
| Ryan Preblick | Chief Financial Officer | 284,751 | 0.24% | Jun 10, 2026 |
| Jeffrey W. Burris | Chief Legal Officer | 71,518 | 0.06% | Mar 5, 2026 |
| Patrick A. Barry | Chief Commercial Officer | 31,380 | 0.03% | Feb 12, 2026 |
| Bethany Sensenig | Director | – | – | Nov 4, 2026 |
| Georges Gemayel | Director | 42,009 | 0.04% | Nov 4, 2026 |
| Carrolee Barlow | Director | 41,652 | 0.04% | Nov 4, 2026 |
| Barbara Ryan | Director | 12,242 | 0.01% | May 14, 2026 |
| David E. Wheadon | Director | 30,780 | 0.03% | May 14, 2026 |
| Stuart A. Kingsley | Director | 12,100 | 0.01% | May 14, 2026 |
| Mark Stejbach | Director | 27,087 | 0.02% | May 14, 2026 |
| Daniel A. Ninivaggi | Director | 27,163 | 0.02% | May 14, 2026 |
| Keith Humphreys | Director | 16,042 | 0.01% | May 14, 2026 |
| Juliet Thompson | Director | 18,748 | 0.02% | May 14, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Frank Mottola SVP, Chief Tech. Ops. Officer | Nov 2, 2026 | Other | +30,099 | – | – | 30,099 |
| Timothy C. Dec SVP, Chief Financial Officer | Nov 2, 2026 | Other | +14,059 | – | – | 14,059 |
| Carrolee Barlow Director | Nov 2, 2026 | Other | +41,652 | – | – | 41,652 |
| Padmanabh P. Bhatt SVP of IP, CSO | Nov 2, 2026 | Other | +28,702 | – | – | 28,702 |
| Georges Gemayel Director | Nov 2, 2026 | Other | +42,009 | – | – | 42,009 |
| Jack A. Khattar Chief Executive Officer, Director | Nov 2, 2026 | Other | +1,475,569 | – | – | 1,475,569 |
| Jack A. Khattar Chief Executive Officer, Director | Nov 2, 2026 | Other | +1,937,986 | – | – | 1,937,986 |
| Jonathan Rubin SVP, Chief Medical Officer | Nov 2, 2026 | Other | +21,529 | – | – | 21,529 |
| Woodrow D. Anderson Chief Accounting Officer | Aug 27, 2026 | Buy | +1,500 | $35.69 | $53.54K | 27,638 |
| Woodrow D. Anderson Chief Accounting Officer | Aug 5, 2026 | Buy | +1,500 | $36.28 | $54.42K | 26,138 |
| Christian Heidbreder Chief Scientific Officer | Jul 10, 2026 | Sale(10b5-1 plan) | −18,586 | $41.14 | $764.63K | 209,337 |
| Joseph Ciaffoni Chief Executive Officer, Director | Jun 22, 2026 | Tax withholding | −612,549 | $38.32 | $23.47M | 790,330 |
| Joseph Ciaffoni Chief Executive Officer, Director | Jun 22, 2026 | Option exercise | +1,266,903 | – | – | 1,402,879 |
| Christian Heidbreder Chief Scientific Officer | Jun 11, 2026 | Sale(10b5-1 plan) | −18,586 | $38.06 | $707.38K | 227,923 |
| Ryan Preblick Chief Financial Officer | Jun 8, 2026 | Sale(10b5-1 plan) | −36,000 | $37.70 | $1.36M | 284,751 |
| Keith Humphreys Director | May 13, 2026 | Award | +6,518 | – | – | 16,042 |
| Juliet Thompson Director | May 13, 2026 | Award | +6,518 | – | – | 12,973 |
| Daniel A. Ninivaggi Director | May 13, 2026 | Award | +6,518 | – | – | 27,163 |
| Barbara Ryan Director | May 13, 2026 | Award | +6,518 | – | – | 12,242 |
| David E. Wheadon Director | May 13, 2026 | Award | +10,430 | – | – | 30,780 |
| Mark Stejbach Director | May 13, 2026 | Award | +6,518 | – | – | 27,087 |
| Stuart A. Kingsley Director | May 13, 2026 | Award | +6,518 | – | – | 12,100 |
| Juliet Thompson Director | May 12, 2026 | Tax withholding | −1,117 | $38.28 | $42.76K | 6,455 |
| Ryan Preblick Chief Financial Officer | Mar 14, 2026 | Option exercise | +6,302 | – | – | 323,594 |
| Ryan Preblick Chief Financial Officer | Mar 14, 2026 | Tax withholding | −2,843 | $31.11 | $88.45K | 320,751 |
| Barbara Ryan Director | Mar 13, 2026 | Buy | +8 | $31.09 | $249 | 5,724 |
| Barbara Ryan Director | Mar 9, 2026 | Buy | +31 | $32.56 | $1.01K | 5,716 |
| Stuart A. Kingsley Director | Mar 6, 2026 | Buy | +940 | $31.87 | $29.96K | 5,582 |
| Christian Heidbreder Chief Scientific Officer | Mar 3, 2026 | Tax withholding | −45,797 | $31.98 | $1.46M | 246,509 |
| Christian Heidbreder Chief Scientific Officer | Mar 3, 2026 | Option exercise | +101,544 | – | – | 292,306 |
| Ryan Preblick Chief Financial Officer | Mar 3, 2026 | Tax withholding | −87,597 | $31.98 | $2.80M | 230,343 |
| Ryan Preblick Chief Financial Officer | Mar 3, 2026 | Option exercise | +86,949 | – | – | 317,292 |
| Jeffrey W. Burris Chief Legal Officer | Mar 3, 2026 | Tax withholding | −36,032 | $31.98 | $1.15M | 71,518 |
| Jeffrey W. Burris Chief Legal Officer | Mar 3, 2026 | Option exercise | +79,893 | – | – | 107,550 |
| Woodrow D. Anderson Chief Accounting Officer | Mar 3, 2026 | Option exercise | +18,364 | – | – | 29,657 |
| Woodrow D. Anderson Chief Accounting Officer | Mar 3, 2026 | Tax withholding | −2,682 | $31.98 | $85.77K | 24,638 |
| Woodrow D. Anderson Chief Accounting Officer | Mar 3, 2026 | Option exercise | +5,946 | – | – | 27,320 |
| Woodrow D. Anderson Chief Accounting Officer | Mar 3, 2026 | Tax withholding | −8,283 | $31.98 | $264.89K | 21,374 |
| Joseph Ciaffoni Chief Executive Officer, Director | Feb 10, 2026 | Award | +79,976 | – | – | 135,976 |
| Christian Heidbreder Chief Scientific Officer | Feb 10, 2026 | Award | +33,622 | – | – | 190,762 |
| Woodrow D. Anderson Chief Accounting Officer | Feb 10, 2026 | Award | +6,903 | – | – | 11,293 |
| Ryan Preblick Chief Financial Officer | Feb 10, 2026 | Award | +37,358 | – | – | 317,940 |
| Jeffrey W. Burris Chief Legal Officer | Feb 10, 2026 | Award | +26,897 | – | – | 27,657 |
| Patrick A. Barry Chief Commercial Officer | Feb 10, 2026 | Award | +31,380 | – | – | 31,380 |
| David E. Wheadon Director | Jan 26, 2026 | Award | +5,955 | – | – | 20,350 |
| Daniel A. Ninivaggi Director | Jan 26, 2026 | Award | +3,722 | – | – | 20,645 |
| Stuart A. Kingsley Director | Jan 26, 2026 | Award | +3,722 | – | – | 4,642 |
| Juliet Thompson Director | Jan 26, 2026 | Award | +3,722 | – | – | 7,572 |
| Barbara Ryan Director | Jan 26, 2026 | Award | +3,722 | – | – | 5,685 |
| Mark Stejbach Director | Jan 26, 2026 | Award | +3,722 | – | – | 20,569 |
| Keith Humphreys Director | Jan 26, 2026 | Award | +3,722 | – | – | 9,524 |
| Keith Humphreys Director | Jan 5, 2026 | Buy | +775 | $35.39 | $27.43K | 5,802 |
| Mark Stejbach Director | Jan 5, 2026 | Buy | +775 | $35.39 | $27.43K | 16,847 |
| Barbara Ryan Director | Jan 5, 2026 | Buy | +775 | $35.39 | $27.43K | 1,963 |
| David E. Wheadon Director | Jan 5, 2026 | Buy | +1,771 | $35.39 | $62.68K | 14,395 |
| Daniel A. Ninivaggi Director | Jan 5, 2026 | Buy | +775 | $35.39 | $27.43K | 16,923 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Supernus's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Christian Heidbreder Officer | Jul 10, 2026 | 18,586 | $764.63K | Jul 10, 2026 | Restricted Stock Vesting |
| Christian Heidbreder Officer | Jun 11, 2026 | 18,586 | $707.38K | Jun 11, 2026 | Restricted Stock Vesting |
| Ryan Preblick Officer | Jun 8, 2026 | 36,000 | $1.36M | Jun 8, 2026 | Restricted Stock Vesting |
| Ryan Preblick Officer | Jun 8, 2026 | 36,000 | $1.36M | Jun 8, 2026 | Restricted Stock Vesting |
| Cetani Cynthia C Officer | Nov 7, 2025 | 121,737 | $3.73M | Nov 7, 2025 | Restricted Stock Units |
| Crossley Mark Affiliate | Sep 8, 2025 | 26,463 | $655.00K | Sep 8, 2025 | Open Market |
| Mark Crossley affiliate | Sep 8, 2025 | 183,938 | $4.59M | Sep 8, 2025 | Vesting of Restricted Stock Units |
| Mark Crossley affiliate | Sep 4, 2025 | 30,000 | $744.01K | Sep 4, 2025 | Vesting of Restricted Stock Units |
| Mark Crossley affiliate | Aug 28, 2025 | 52,320 | $1.28M | Aug 28, 2025 | Vesting of Restricted Stock Units |
| Christian Heidbreder Officer | Mar 20, 2024 | 23,470 | $488.99K | Mar 13, 2024 | Share Option Exercise |
| Cetani Cynthia C Officer | Mar 14, 2024 | 66,073 | $1.39M | Mar 14, 2024 | Performance Stock Units |
Congress trades
5 trades in Supernus reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Mar 3, 2026 | $1K–15K | Apr 7, 2026 |
| Gilbert Cisneros CA31 | Bought | Dec 11, 2025 | $1K–15K | Jan 12, 2026 |
| Gilbert Cisneros CA31 | Sold (part) | Oct 9, 2025 | $1K–15K | Nov 18, 2025 |
| Gilbert Cisneros CA31 | Bought | Mar 24, 2025 | $1K–15K | Apr 7, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Dec 23, 2022 | $1K–15K | Jan 13, 2023 |
See a number that looks wrong?